Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.

By Lars A. Carlson, G. Rosenhamer. Acta Medica Scandinavica, 2009

687 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. (2001, background): “Other clinical end point trials have been conducted with drugs that have a prominent effect on HDL-C and triglycerides, most particularly fibric acids(12-18) or niacin.(15,16) However, subjects in these trials have also had relatively high concentrations of total cholesterol or LDL-C and, when measu”
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. (2016, positive): “Importantly, an often forgotten controlled trial of 555 consecutive post-MI patients from Sweden, as the only one of all fibrate trials, recruited particularly patients with high triglycerides and compared triglyceride- and cholesterol-lowering treatment with fibrate and niacin in combination versus”